Cargando…

Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study

Preclinical studies have shown that the gut microbiota can play a role in schizophrenia (SCH) pathogenesis via the gut-brain axis. However, its role in the antipsychotic treatment response is unclear. Here, we present a 24-week follow-up study to identify gut microbial biomarkers for SCH diagnosis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Xiuxia, Wang, Yunpeng, Li, Xue, Jiang, Jiajun, Kang, Yulin, Pang, Lijuan, Zhang, Peifen, Li, Ang, Lv, Luxian, Andreassen, Ole A., Fan, Xiaoduo, Hu, Shaohua, Song, Xueqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355081/ https://www.ncbi.nlm.nih.gov/pubmed/34376634 http://dx.doi.org/10.1038/s41398-021-01531-3

Ejemplares similares

The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
por: Li, Xue, et al.
Publicado: (2021)

Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia
por: Tao, Qi, et al.
Publicado: (2020)

Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity
por: Pang, Lijuan, et al.
Publicado: (2017)

Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia
por: Song, Xueqin, et al.
Publicado: (2014)

APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia
por: Song, Xueqin, et al.
Publicado: (2014)

N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients
por: Zong, Xiaofen, et al.
Publicado: (2015)

Oxidative stress impairs cognitive function by affecting hippocampal fimbria volume in drug-naïve, first-episode schizophrenia
por: Jia, Rufei, et al.
Publicado: (2023)

Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2022)

Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
por: Wu, Renrong, et al.
Publicado: (2019)

Disrupted asymmetry of inter- and intra-hemispheric functional connectivity in patients with drug-naive, first-episode schizophrenia and their unaffected siblings
por: Zhu, Furong, et al.
Publicado: (2018)

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2021)

Decreased Resting-State Interhemispheric Functional Connectivity Correlated with Neurocognitive Deficits in Drug-Naive First-Episode Adolescent-Onset Schizophrenia
por: Liu, Yi, et al.
Publicado: (2017)

Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia
por: Li, Zongchang, et al.
Publicado: (2015)

Fractional amplitude of low frequency fluctuation in drug-naïve first-episode patients with anorexia nervosa: A resting-state fMRI study
por: Lai, Jianbo, et al.
Publicado: (2020)

Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers
por: Wang, Shuying, et al.
Publicado: (2023)

New insight in the cross-talk between microglia and schizophrenia: From the perspective of neurodevelopment
por: Li, Jingjing, et al.
Publicado: (2023)

Striatum-related spontaneous coactivation patterns predict treatment response on positive symptoms of drug-naive first-episode schizophrenia with risperidone monotherapy
por: Zong, Xiaofen, et al.
Publicado: (2023)

T24. REDOX REGULATORS AND OXIDATIVE STRESS IN SCHIZOPHRENIA
por: Bentsen, Havard, et al.
Publicado: (2018)

Microglia activation in the offspring of prenatal Poly I: C exposed rats: a PET imaging and immunohistochemistry study
por: Li, Xue, et al.
Publicado: (2018)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
por: Sun, Qiaoling, et al.
Publicado: (2022)

Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples
por: Li, Huabing, et al.
Publicado: (2019)

DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia
por: Zong, Xiaofen, et al.
Publicado: (2021)

Abnormal interhemispheric and intrahemispheric functional connectivity dynamics in drug‐naïve first‐episode schizophrenia patients with auditory verbal hallucinations
por: Wei, Yarui, et al.
Publicado: (2022)

Ameliorative patterns of grey matter in patients with first-episode and treatment-naïve schizophrenia
por: Li, Mingli, et al.
Publicado: (2023)

Depth‐dependent abnormal cortical myelination in first‐episode treatment‐naïve schizophrenia
por: Wei, Wei, et al.
Publicado: (2020)

T121. BLUNTED AFFECT EARLY PROGRESSION IN DRUG-NAïVE FIRST EPISODE SCHIZOPHRENIA PATIENTS: 10-WEEK FOLLOW UP
por: Kagan, Simão, et al.
Publicado: (2020)

Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study
por: Wu, Zhiwei, et al.
Publicado: (2021)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
por: Liu, Haixia, et al.
Publicado: (2022)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients
por: Li, Zongchang, et al.
Publicado: (2023)

The common variants implicated in microstructural abnormality of first episode and drug-naïve patients with schizophrenia
por: Ren, H. Y., et al.
Publicado: (2017)

Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2010)

Impaired Binocular Depth Perception in First-Episode Drug-Naive Patients With Schizophrenia
por: Wang, Zhengchun, et al.
Publicado: (2018)

Age-associated network controllability changes in first episode drug-naïve schizophrenia
por: Tang, Biqiu, et al.
Publicado: (2022)

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
por: Wei, Qianqian, et al.
Publicado: (2022)

The importance of blood count and oxidative stress in the drug-naïve first episode schizophrenia
por: Rog, J., et al.
Publicado: (2022)

Sex-Specific Patterns of Aberrant Brain Function in First-Episode Treatment-Naive Patients with Schizophrenia
por: Lei, Wei, et al.
Publicado: (2015)

Disassociated and concurrent structural and functional abnormalities in the drug-naïve first-episode early onset schizophrenia
por: Li, Qiang, et al.
Publicado: (2022)

Altered static and dynamic functional connectivity of habenula in first-episode, drug-naïve schizophrenia patients, and their association with symptoms including hallucination and anxiety
por: Xue, Kangkang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0m3m0d61u0ev4eta3dsuf4d7q5